Back to today’s briefing

Story perspectives

Moderna Slashes Workforce 10% Amid Vaccine Sales Decline

7/31/2025

26 4

Summary

Story summary

Moderna will reduce its workforce by 10%, bringing employee numbers below 5,000 by year-end due to falling COVID vaccine sales.
CEO Stéphane Bancel aims to cut annual operating expenses by $1.5 billion by 2027.
The company has already decreased R&D and manufacturing costs in response to competitive pressures and policy shifts.
Moderna's stock has declined over 20% this year, with first-quarter revenues at just $100 million.

1 of 1

Story summary

Moderna will reduce its workforce by 10%, bringing employee numbers below 5,000 by year-end due to falling COVID vaccine sales.
CEO Stéphane Bancel aims to cut annual operating expenses by $1.5 billion by 2027.
The company has already decreased R&D and manufacturing costs in response to competitive pressures and policy shifts.
Moderna's stock has declined over 20% this year, with first-quarter revenues at just $100 million.